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ABSTRACT: Lytic transglycosylases catalyze the cleavage of the â-1,4-glycosidic bond between N-
acetylmuramic acid (MurNAc) and N-acetylglucosamine (GlcNAc) in peptidoglycan with concomitant
formation of a 1,6-anhydro bond in the MurNAc residue. To understand the reaction mechanism of
Escherichia coli lytic transglycosylase Slt35, three crystal structures have been determined of Slt35 in
complex with two different peptidoglycan fragments and with the lytic transglycosylase inhibitor bulgecin
A. The complexes define four sugar-binding subsites (-2, -1, +1, and +2) and two peptide-binding
sites in a large cleft close to Glu162. The Glu162 side chain is between the -1 and +1 sugar-binding
sites, in agreement with a function as catalytic acid/base. The complexes suggest additional contributions
to catalysis from Ser216 and Asn339, residues which are conserved among the MltB/Slt35 lytic
transglycosylases.
Lytic transglycosylases catalyze the cleavage of the â-1,4-
glycosidic bond between N-acetylmuramic acid (MurNAc)1
and N-acetylglucosamine (GlcNAc) residues in peptidoglycan
with concomitant formation of a 1,6-anhydro bond in the
MurNAc residue (anhMurNAc) (1). These bacterial enzymes
play a role in peptidoglycan metabolism, but their precise
functions are not known. Among others, they have been
implicated as space makers for the insertion of new pepti-
doglycan into the cell wall during remodeling and cell growth
(2) and as cell wall zippers during cell division (3).
Furthermore, they may function in the recycling of old
peptidoglycan material (4) or may make pores in the
peptidoglycan layer to allow transport of DNA and proteins
across the cell wall (5). Because peptidoglycan is unique
and essential for bacteria, lytic transglycosylases may be
effective targets for drug design (6).
Structural research on lytic transglycosylases has so far
resulted in the X-ray structures of the 70 kDa soluble lytic
transglycosylase Slt70 (7) and the 36 kDa soluble lytic
transglycosylase Slt35 of Escherichia coli (8, 9). Slt35 is a
fully active, soluble form of the 40 kDa membrane-anchored
lytic transglycosylase B (MltB). Limited proteolysis of the
peptide bond between residues 39 and 40 results in the
release of Slt35 (residues 40-361) (10-12). The structure
of Slt35 shows three domains named the R, â, and core
domains. The core domain resembles the fold of goose-type
lysozyme and the catalytic domain of Slt70 (9). It contains
Glu162, which coincides with the catalytic Glu478 of Slt70
and Glu73 of goose-type lysozyme after superposition. Near
Glu162, a deep groove is present in the core domain, where
a GlcNAc residue was found to occupy carbohydrate-binding
subsite -2 (for binding site nomenclature, see ref 13).
Furthermore, the core domain contains an EF-hand calcium-
binding site (9, 14), which is about 20 Å from Glu162. Both
Slt35 and Slt70 are exo-muramidases that require the peptide
side chains in peptidoglycan for activity (15, 16). It is
believed that the N-terminal, doughnut-shaped domain of
Slt70 and the “exo-loop” of Slt35 (residues 99-108) impose
this exo-muramidase activity (9).
To further analyze the active site architecture of Slt35 and
to understand its peptidoglycan cleavage mechanism, we
determined the binding mode of (GlcNAc)2 (chitobiose), the
peptidoglycan fragment GlcNAc-MurNAc-L-Ala-D-Glu (muro-
dipeptide), and the glycopeptide bulgecin A in the active
site of Slt35 by X-ray crystallography (see Figure 1 for
schematic diagrams of these compounds). Bulgecin A is a
natural lytic transglycosylase inhibitor containing a 4-O-
sulfonated GlcNAc residue and a 4-hydroxy-5-(hydroxy-
methyl)-L-proline with a linked taurine residue (6, 17, 18).
This study allows us to define four sugar-binding sites and
two peptide-binding sites. Furthermore, the complexes sug-
gest contributions to catalysis from Glu162, Ser216, and
Asn339, residues which are conserved among the MltB/Slt35
lytic transglycosylases.
MATERIALS AND METHODS
Crystallization. The Slt35 protein was isolated as described
previously (11). The resulting protein solution consisted of
28 mg/mL Slt35, 1% polyethylene glycol 20000 (PEG20K),
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150 mM NaCl, and 20 mM HEPES buffer (pH 7.5). Prior
to the crystallization experiments, this solution was diluted
four times with 10 mM Tris-HCl (pH 7.2) and 1% 2-pro-
panol, and subsequently dialyzed for 6 h against 10 mM Tris-
HCl buffer (pH 7.2) and 1% 2-propanol. This was done to
remove ethylene glycol, which appeared to be bound in the
active site of the native Slt35 structure (9) and which
probably originated from the PEG20K. The enzyme was
crystallized using the hanging drop vapor diffusion method
with 3 íL of protein solution and 3 íL of reservoir solution
consisting of 0.1 M bicine-NaOH buffer (pH 7.8) only (8).
Soaking Experiments. A 25% (w/v) PEG20K stock solu-
tion was dialyzed against pure water using a membrane with
a 6-10 kDa cutoff for 24 h. The concentration of the
PEG20K was determined with a GPR 11-37 refractometer
(Index Instruments). The Slt35 crystals were repeatedly
washed in a solution of 50 mM Tris-HCl buffer (pH 8.0)
and 2% dialyzed PEG20K. Subsequently, one crystal was
soaked in a solution of 50 mM Tris-HCl buffer (pH 8.0),
2% dialyzed PEG20K, and 17 mM N-(acetylglucosamyl)-
N-(acetylmuramyl)-L-alanyl-D-glutamic acid (murodipeptide
obtained from Sigma) for 4 h. A second crystal was soaked
for 18.5 h in a solution of 50 mM Tris-HCl buffer (pH 8.0),
2% dialyzed PEG20K, 1 mM CaCl2, and 20 mM bulgecin
A [kindly provided by A. J. Dijkstra (F. Hoffmann-LaRoche
Ltd.)]. A third crystal was also soaked in this bulgecin A
solution, but after 2 min, it was transferred to a solution of
50 mM Tris-HCl buffer (pH 8.0), 2% dialyzed PEG20K, 1
mM CaCl2, 10 mM bulgecin A, and 10 mM chitobiose
(purchased from Sigma) and soaked for 1/2 min.
Data Collection and Processing. For the diffraction
experiments, the crystals were flash-frozen at 120 K in a
stream of evaporating nitrogen after having been soaked for
30-60 s in a cryoprotectant consisting of 50 íL of 87%
glycerol and 50 íL of soaking solution. The Slt35-
murodipeptide and Slt35-bulgecin A-chitobiose data were
collected in house on DIP image plates (MacScience) using
CuKR radiation from a Nonius FR591 rotating anode
generator with Franks’ mirrors. The Slt35-bulgecin A data
set was measured at the X11 beamline of the EMBL
outstation at DESY (Hamburg, Germany) using 0.9057 Å
radiation and a FastMar-Research image plate detector sys-
tem. All data were processed with DENZO and SCALEPACK
(19), and the measured intensities were converted to structure
factor amplitudes with programs from the Groningen BIO-
MOL software package. Data collection statistics can be
found in Table 1A.
Refinement. For the refinement, the same reflections that
were selected for the Rfree calculations of the native data set
(10% of the reflections) were set aside (20). As a starting
model, the refined native Slt35 structure to 1.7 Å resolution
was used, including the solvent molecules and alternate side
chain conformations (9). After rigid-body refinement (3.5-
8.0 Å resolution), the models were refined in several cycles
of Powell energy minimization, occupancy refinement of
alternate side chain conformations, and overall and individual
B-factor refinement with the program X-PLOR, version 3.843
(21), and addition of solvent and substrate molecules and
manual rebuilding in O (22). Only the solvent molecules and
alternate side chains with electron density above 1ó in 2Fo
- Fc maps we kept during the refinement. The force
constants and parameters used for the sugars were those
described by Weis et al. (23) as implemented in the X-PLOR
geometry files. The coordinates, parameter file, and topology
file of bulgecin A were derived from a desulfonated form
of bulgecin (17). Low-resolution diffraction data to 20 Å
were included, and a bulk solvent correction was applied.
The application of an anisotropic B-factor scaling and a
resolution-dependent and 1/ó2 weighting scheme resulted in
lower Rfree values and smaller differences between Rwork and
Rfree. The last refinement cycle was repeated with all data,
including the test set. The final refinement statistics for the
complex structures are summarized in Table 1B. Stereo-
chemistry was inspected with the program PROCHECK (24).
RESULTS
Three crystals of Slt35 were successfully soaked with the
murodipeptide N-(acetylglucosamyl)-N-(acetylmuramyl)-L-
alanyl-D-glutamic acid, the glycopeptide bulgecin A, and a
mixture of bulgecin A and chitobiose, respectively (Figure
1). In each complex, a calcium ion is bound in the EF-hand
calcium-binding site in a fashion similar to that described
previously (14). The side chain of the first N-terminal residue
Met40 and an internal stretch of 8-10 residues (99-108 or
101-108) do not exhibit interpretable electron density in
Fo - Fc and 2Fo - Fc omit maps and have been omitted
FIGURE 1: Schematic representation of compounds soaked in the Slt35 crystals. (A) The murodipeptide N-(acetylglucosamyl)-N-
(acetylmuramyl)-L-alanyl-D-glutamic acid. (B) The glycopeptide bulgecin A. Bulgecins are produced by Pseudomonas mesoacidophila and
Pseudomonas acidophila in three different forms, A-C (35). Bulgecin A constitutes the major component and has linked a taurine residue
(NHCH2CH2SO3) to the 4-hydroxy-5-(hydroxymethyl)-L-proline (indicated as “hydroxyproline”) via an amide bond. Instead of a taurine
residue, bulgecins B and C have linked a â-alanine (NHCH2CH2COOH) or a free OH group. (C) The disaccharide chitobiose, (GlcNAc)2.
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from the models. All residues are found in the allowed re-
gions of the Ramachandran diagram according to PROCHECK
(24) and have good stereochemistry. Details of the structure
determinations of the three complexes are summarized in
Table 1.
Slt35-Murodipeptide Complex. Two murodipeptides
(murodipeptides A and B) were found to be bound in the
active site cleft of Slt35 (Figure 2A). Murodipeptide A binds
with its GlcNAc and MurNAc residues in subsites -2 and
-1, respectively, while murodipeptide B occupies subsites
+1 and +2 (Figures 3A and 4A). Because its electron density
was weak, murodipeptide A was refined with an occupancy
of 0.5. However, some residual density remained at subsites
-2 and -1, in which a glycerol molecule and six water
molecules could be placed with an occupancy of 0.5. The
density for the -1 MurNAc residue is not very clear. Several
different orientations may be present for this residue. In the
model presented here, the -1 MurNAc has been modeled
in the energetically most favorable 4C1 chair conformation,
with the O1 hydroxyl group in a â-anomeric configuration.
The GlcNAc residue at subsite -2 has a full 4C1 chair
conformation and binds with its N-acetyl group in a cavity
that predominantly consists of the aromatic rings of Phe226,
Tyr259, and Tyr338. The N-acetyl group is within hydrogen
bonding distance of the Ser230 Oç atom and the Met227 N
atom. The O3-hydroxyl group may form a hydrogen bond
to the Tyr259 side chain, whereas the O6-hydroxyl group is
within hydrogen bonding distance of the carbonyl oxygen
atom of the L-Ala residue at subsite -1.
The MurNAc-L-Ala-D-Glu moiety of murodipeptide A
binds in subsite -1. The electron density for the N-acetyl
group permits two orientations with the group pointing either
upward or downward. In the down position, it has no
interactions with protein or ligand atoms, while in the up
position, its O7 and N2 atoms are within hydrogen bonding
distance of Gln98 and a water molecule bound to Ser216,
respectively. The position of the MurNAc O1 atom is
uncertain, because of its lack of electron density. The O6-
hydroxyl group is within hydrogen bonding distance of
Tyr338 and Glu162 (Figure 4A). The D-lactyl moiety and
Table 1: Data Collection and Refinement Statistics
murodipeptide bulgecin A bulgecin A and chitobiose
(A) Data Collection
resolution (Å) (last shell) 23.2-2.02 (2.05-2.02) 32.8-1.97 (2.00-1.97) 23.6-2.47e (2.51-2.47)
no. of total reflections 108180 205843 35069
no. of unique reflection 26200 27987 13028
completeness (%) (last shell) 99.0 (99.9) 99.3 (85.0) 90.3 (69.3)
Rmergea (%) (last shell) 6.7 (26.7) 5.3 (24.9) 3.7 (11.8)
unit cell dimensions (a, b, c in Å) 58.4, 67.8, 98.9 58.4, 67.8, 97.7 58.6, 67.8, 97.8
(B) Refinement
resolution range (Å) 20.0-2.02 20.0-1.97 20.0-2.47
no. of total reflections 25892 27351 12912
no. of reflections in work set 23291 24588 11633
final R-factor (%)b 16.8 17.0 17.9
Rwork (%)b 16.5 16.8 17.4
Rfree (%)b 20.2 20.0 24.1
rmsd
bond lengths (Å)c 0.006 0.006 0.007
bond angles (deg)c 1.2 1.2 1.3
dihedral angles (deg)c 21.8 21.7 22.3
improper angles (deg)c 1.04 1.05 1.03
no. of non-H protein atoms 2546 2537 2508
no. of residues 40-100, 109-361 40-100, 109-361 40-98, 109-361
no. of alternate side chains 12 10 6
no. of water molecules 362 286 200
no. of substrate atoms 96 35 65
no. of calcium ions 1 1 1
no. of glycerol molecules 1 0 0
average B-factor (Å2)
all atoms 18.2 23.5 31.7
main chain atoms 14.1 19.9 30.4
side chains 16.9 23.2 31.2
glycerol 23.3 - -
murodipeptided
GlcNAc 20.7 (A), 37.9 (B)
MurNAc 23.1 (A), 51.1 (B)
L-Ala 23.7 (A), 65.5 (B)








a Rmerge ) “jI - 〈I〉j/“I. b R-factor ) “jjFobsj - jFcalcjj/“jFobsj. Rwork and Rfree are defined for reflections with F > 0. The final R-factor is
calculated for all reflections with F > 0 in the resolution range. c With respect to the parameters of Engh and Huber (34). d Muropeptide A is bound
in subsites -2 and -1; muropeptide B is found in subsites +1 and +2. e The effective resolution is 2.57 Å.
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the dipeptide are stabilized by Arg188 and Arg187, respec-
tively. Interestingly, the bound murodipeptide A seems to
stabilize residues 99 and 100 of the exo-loop (residues 99-
108), which were not visible in the native 1.7 Å Slt35
structure. This is probably due to hydrophobic interactions
between Pro100 and the dipeptide moiety of murodipeptide
A.
Murodipeptide B binds with its GlcNAc residue in subsite
+1, and the MurNAc-L-Ala-D-Glu moiety at subsite +2.
Both GlcNAc and MurNAc exhibit clear density for a 4C1
chair conformation (Figure 3A). GlcNAc is within hydrogen
bonding distance of Glu162 and Asn339, while the +2
MurNAc-L-Ala-D-Glu moiety might form hydrogen bonds
with residue 161 and His343 (Figure 4A). The MurNAc
residue clearly exhibits electron density for an O1-hydroxyl
group in an R-anomeric configuration, which is probably due
to the formation of a hydrogen bond between the O1 atom
and the side chain of Gln207 of a symmetry-related molecule.
The L-Ala-D-Glu dipeptide makes mainly van der Waals and
hydrophobic interactions with the side chains of Tyr117,
Lys120, and Phe121.
Slt35-Bulgecin A Complex. Bulgecin A is bound in an
extended conformation with the GlcNAc residue in a 4C1
chair conformation at the -2 subsite and the hydroxyproline
residue at the -1 subsite (Figure 4B). The GlcNAc residue
occupies the same position as the GlcNAc residue of
FIGURE 2: Stereoviews of Slt35-substrate complexes with domain and secondary structure labeling. (A) The Slt35-murodipeptide complex
with murodipeptide A in subsites -2 and -1 and murodipeptide B in subsites +1 and +2. (B) The Slt35-bulgecin A-chitobiose complex
with bulgecin A in subsites -2 and -1 and chitobiose in subsites +1 and +2. The catalytic acid/base Glu162 is located between subsites
-1 and +1. Glu162, the substrates, and the calcium ion in the EF-hand calcium-binding site are shown as ball-and-stick representations.
The R, â, and core domains are colored green, red, and yellow, respectively, while the EF-hand loop (residues 237-245) and the calcium
ion are colored light blue. The residues of the exo-loop (residues 99-108) run from R-helix H3 to R-helix H4, but due to flexibility, most
of these residues could not be identified in the electron density maps. Only for the Slt35-murodipeptide and Slt35-bulgecin A complexes
electron density was present for residues 99 and 100 of the exo-loop (magenta in panel A), and therefore, these residues could be included
in the models. This figure was produced with MOLSCRIPT (36).
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murodipeptide A (see above) and forms the same hydrogen
bonds. However, due to small protein movements (see
below), the O6-hydroxyl group is now within hydrogen
bonding distance of the side chains of Arg188 and Tyr191.
Furthermore, the N-acetyl nitrogen is now within hydrogen
bonding distance of the carbonyl oxygen of Tyr338 (Figure
FIGURE 3: Stereoviews of the Slt35 complexes superimposed on the simulated annealing omit and óA-weighted Fo - Fc electron density
maps. (A) Murodipeptides A and B (black bonds) and glycerol (white bonds) in the Slt35-murodipeptide complex. (B) Bulgecin A in the
Slt35-bulgecin A complex. (C) Bulgecin A and chitobiose in the Slt35-bulgecin A-chitobiose complex. The superimposed electron
density maps are contoured at the 2.0ó level for the Slt35-bulgecin A and Slt35-bulgecin A-chitobiose complexes and at the 1.5ó level
for the Slt35-murodipeptide complex. The densities have been calculated from the final models excluding the particular molecule(s) using
a standard simulated annealing protocol in X-PLOR (37, 38). The substrate atoms and Glu162 are shown as ball-and-stick representations
with carbon atoms in black, nitrogen atoms in gray, oxygens in white, and sulfur atoms as larger gray balls.
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4B). The GlcNAc 4-O-sulfonate group has no direct hydro-
gen bonding interactions with the protein.
At subsite -1, the 5-hydroxymethyl oxygen of the
modified hydroxyproline residue is within hydrogen bonding
distance of the O2 atom of Glu162 and the Nä2 atom of
Asn339, respectively. The carbonyl oxygen of the hydroxy-
proline moiety may form a hydrogen bond to the Oç of
Ser216. Probably, a weak electrostatic interaction is present
between the carboxylate group of Glu162 and the amine
nitrogen in the proline ring (distance of 4.1 Å). This atom is
FIGURE 4: Schematic drawing of the hydrogen bonding interactions (dotted lines) in the Slt35 complexes. (A) The Slt35-murodipeptide
complex. (B) The Slt35-bulgecin A complex. (C) The Slt35-bulgecin A-chitobiose complex. In all three structures, Glu162 is displayed
as a base, although the acid form cannot be excluded. Residue Gln207# is from a symmetry-related molecule.
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most likely protonated at the pH of the experiment (pH 8.0),
as the pKa of this group is about 10.6 (25).
The taurine residue (NHCH2CH2SO3) is linked to the
carbonyl group of the hydroxyproline via a peptide bond.
The sulfonyl group has no direct hydrogen bonds with Slt35.
Its atomic displacement parameters are higher than those of
the rest of bulgecin (between 50 and 60 Å2), suggesting
flexibility. The N10 atom of the taurine residue may form
two water-mediated hydrogen bonds: one to the Nä2 atom
of Asn339 and one to a sulfonyl oxygen of the taurine.
Bulgecin A is an effective inhibitor of the lytic transgly-
cosylase Slt70 of E. coli (6), but less so of Slt35 (16). In an
attempt to understand this difference, we compared the
binding modes of bulgecin A in Slt70 (26) and Slt35. In
both enzymes, the inhibitor binds in a similar extended
conformation. However, in Slt70 the N10 atom of bulgecin
A makes a hydrogen bond to the carboxylate group of
Glu583, but to a water molecule in Slt35. Both the Glu583
side chain and the water molecule are within hydrogen
bonding distance of the Nä2 atom of a conserved asparagine
residue (Asn553 in Slt70 and Asn339 in Slt35). Second, the
O3 atom of the GlcNAc residue in bulgecin A makes two
hydrogen bonds in Slt70 (to the OŁ atom of Tyr533 and the
Oç1 atom of Thr501), but one in Slt35 (to the OŁ atom of
Tyr259). Third, the O6 atom of bulgecin A cannot form
hydrogen bonds in Slt70, but in Slt35, it is within hydrogen
bonding distance of the NŁ2 of Arg188 and the OŁ of
Tyr191, residues without an equivalent in Slt70. Fourth,
bulgecin A has extra van der Waals interactions with Slt70
residues Ala554, Gly555, and Pro556 (forming a loop above
subsites -2 and -1). These residues are absent in Slt35.
Finally, bulgecin A has a tighter fit in the active site of Slt70.
The volume of the bulgecin binding pocket is 635 Å3 in Slt70
and 719 Å3 in Slt35, as calculated with the program GRASP
(27). Taken together, these differences may explain why
bulgecin A is a better inhibitor of Slt70 than of Slt35.
Slt35-Bulgecin A-Chitobiose Complex. In the ternary
complex of Slt35 with bulgecin A and chitobiose, the
bulgecin molecule is bound at subsites -2 and -1 in a
fashion similar to that found in the Slt35-bulgecin A
complex (Figures 2B, 3C, and 4C). Chitobiose is bound at
subsites +1 and +2, but in a manner different from that of
the sugar residues of murodipeptide B (Figure 5). On average,
the ring atoms of the +1 and +2 sugars are displaced by
1.6 and 0.6 Å, respectively. The O6-hydroxyl group of the
+2 GlcNAc of chitobiose may form hydrogen bonds to the
carbonyl oxygen atom of Val161 and the N atom of Arg164.
The latter hydrogen bond cannot be formed in the Slt35-
murodipeptide B complex, because of a different rotamer
conformation of the arginine side chain. Like murodipeptide
B, the +2 sugar has its O1 atom in an R-anomeric
configuration stabilized by the side chain of Gln207 of a
symmetry-related molecule.
Whereas the O1 atom of Glu162 is hydrogen bonded to
the O3-hydroxyl group of the +1 GlcNAc residue in the
Slt35-murodipeptide complex, in the Slt35-bulgecin A-chi-
tobiose complex it is within hydrogen bonding distance of
the O4-hydroxyl group of the +1 GlcNAc. Since the O1
atom of Glu162 is supposed to donate a proton to the O4 of
the +1 GlcNAc, it seems likely that the binding of chitobiose
resembles more the sugar binding of peptidoglycan to Slt35
than the binding of the murodipeptide B.
Comparison with Peptidoglycan Binding in Slt70. The
catalytic domains of Slt35 and Slt70 are very similar [root-
mean-square deviation of 1.7 Å for 100 CR atoms (9)]. A
comparison of the observed +1 GlcNAc binding modes in
Slt35 and Slt70 shows that the +1 GlcNAc residue of the
Slt35-bulgecin A-chitobiose complex is in a position
similar to the +1 GlcNAc in the Slt70-1,6-anhydro-
muropeptide complex (ref 28 and Figure 5B). The +1
GlcNAc residues have conserved hydrogen bonding interac-
tions in both proteins with their O3 atoms (to the O1 atom
of the conserved Gln225 and Gln496 in Slt35 and Slt70,
respectively), their O4 atoms (to the O1 atom of the catalytic
acid/base Glu162 and Glu478 in Slt35 and Slt70, respec-
tively), and their N2 atoms (to the backbone carbonyl oxygen
of the catalytic acid/base). In contrast, the +1 GlcNAc
residue of the Slt35-murodipeptide complex occupies a
different position and makes only the latter conserved
hydrogen bond. Because a tight binding of the +1 GlcNAc
residue is important to preventing hydrolysis of the reaction
intermediate (see Discussion), this strengthens the above
conclusion that the chitobiose molecule in the Slt35-
bulgecin A-chitobiose complex resembles more a competent
peptidoglycan binding mode in subsites +1 and +2 than the
murodipeptide B.
An intriguing difference between Slt35 and Slt70 is the
hydrophobicity of their +1 sites. Val161 in Slt35 is
substituted for a glutamine residue in Slt70 (Gln477). The
shorter and hydrophobic valine side chain in Slt35 creates a
hydrophobic pocket, which can accommodate the C6 atom
of the +1 GlcNAc with favorable van der Waals and
hydrophobic interactions with the side chains of Val161,
Phe121, and Tyr344. In Slt70, a hydrogen bonding interaction
is present between the O1 atom of Glu477 and the O6 atom
of the +1 GlcNAc.
ActiVe Site Plasticity. The structural differences between
native Slt35 (9), the Slt35-GlcNAc complex (9), and the
three Slt35 structures presented here were studied by
superimposing their backbone N, CR, and C atoms. The most
significant difference is observed in the active site after
binding of bulgecin A and the GlcNAc molecule in subsite
-2 (Figure 5A), which induces a displacement of the main
chain atoms of Tyr338, Asn339, and His340 by up to 0.9 Å
in the various complex structures with respect to the native
structure. This displacement is accompanied by the formation
of a hydrogen bond between the carbonyl oxygen atom of
Tyr338 and the N2 of the -2 GlcNAc residue in the Slt35-
GlcNAc and Slt35-bulgecin A complexes. This hydrogen
bond is not observed in the Slt35-murodipeptide complex,
which might be due to the partial occupancy. Furthermore,
the displacement allows a hydrogen bond to be formed
between the Nä2 atom of Asn339 and the O9 atom of
bulgecin A, which is in a position similar to the O6 atom of
the -1 MurNAc.
A second significant difference concerns residues Arg187
and Arg188 in the Slt35-bulgecin A complexes, of which
the main chain atoms have moved about 0.7-1.0 Å further
into the active site compared to those in the native structure.
Both residues are involved in substrate binding. Their
movement results in a further narrowing of the active site
cleft and might optimize the hydrogen bonding interactions
with the peptide side chain of the -1 MurNAc.
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DISCUSSION
Peptidoglycan-Binding Cleft. This study shows that the
E. coli lytic transglycosylase Slt35 contains at least four
sugar-binding sites. GlcNAc residues bind in subsites -2
and +1 and MurNAc residues in subsites -1 and +2. Near
the MurNAc binding sites are two peptide-binding regions.
So far, only two other crystal structures of a protein
complexed with a muropeptide have been elucidated: the
T26E mutant of phage T4 lysozyme (T4L) complexed with
the murotetrapeptide (GlcNAc-MurNAc-L-Ala-D-Glu-m-Dap-
D-Ala) in subsites -2 and -1 (29) and Slt70 complexed with
a 1,6-anhydromurotripeptide (GlcNAc-anhMurNAc-L-Ala-
D-Glu-m-Dap) in subsites +1 and +2 (28). The catalytic
domains of Slt35, Slt70, and T4L have a similar fold with a
comparable substrate-binding groove. Comparison of the
complexes shows that both Slt35 and T4L bind a GlcNAc
residue in subsite -2 with the GlcNAc residues making
similar interactions with an aromatic residue (Tyr338 in Slt35
and Phe104 in T4L) and a hydrophobic residue (Met227 in
Slt35 and Leu32 in T4L). Furthermore, these two proteins
bind a MurNAc residue in subsite -1. In both enzymes, the
MurNAc O6 atom is within hydrogen bonding distance of
the O2 atom of the catalytic glutamic acid (Glu162 in Slt35
and Glu11 in T4L), and the free CR carboxylate group of
FIGURE 5: Stereoviews of superpositions of Slt35 and Slt70 made with O (22) and DYNDOM (39). (A) Superpositions of the active sites
of the Slt35 complexes using residues of the core domain (123-136, 148-162, 164-169, 220-261, and 351-359). Thin orange dashed
lines represent native Slt35, thick red dashed lines Slt35-GlcNAc, thin pink lines Slt35-murodipeptide, thick green lines Slt35-bulgecin
A, and thick blue lines Slt35-bulgecin A-chitobiose. (B) Superposition of the +1 subsite of the Slt35-murodipeptide B complex (pink
bonds), the Slt35-bulgecin A-chitobiose complex (blue bonds), and the Slt70-1,6-anhydromuropeptide complex (black bonds). The Slt35
complexes were superimposed on each other as described for panel A. The Slt70-1,6-anhydromuropeptide complex was superimposed on
the Slt35 complexes using the LSQ option in the program O (22) by aligning Gln477, Glu478, Ser487, Gln496, and Tyr552 of Slt70 on
Val161, Glu162, Ser216, Gln225, and Tyr338 of Slt35, respectively. For clarity, only the GlcNAc residue of the 1,6-anhydromuropeptide
in Slt70 is shown. The black labels refer to Slt70 residues, while the pink labels refer to Slt35 residues.
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the D-Glu residue in the MurNAc peptide side chain makes
a salt bridge to an arginine residue (Arg187 in Slt35 and
Arg137 in T4L). Notwithstanding these similarities, it should
be noted that in the T4L mutant the -1 MurNAc residue is
covalently bound (to Glu26), but not in Slt35. In Slt35,
Ala220 is in a position equivalent to that of Glu26 in the
T4L mutant and its Câ atom has a hydrophobic interaction
with the C5 atom of the -1 MurNAc residue.
Comparison of the Slt35-bulgecin A-chitobiose complex
and the Slt70-1,6-anhydromurotripeptide complex shows
that in both enzymes the O4 atom of the +1 GlcNAc is
hydrogen bonded to the O1 atom of the catalytic acid/base
(Glu162 in Slt35 and Glu478 in Slt70). This hydrogen bond
may mimic the interaction of the catalytic Glu with the
glycosidic oxygen of the scissile bond during the cleavage
reaction.
Reaction Mechanism. Lytic transglycosylases catalyze the
cleavage of the â-1,4-glycosidic bond between MurNAc and
GlcNAc with concomitant formation of a 1,6-anhydro bond
in the MurNAc residue. They use a Glu as an acid/base to
facilitate the reaction. In Slt35, Glu162 is located between
the -1 and +1 subsites in a hydrophobic environment
created by the side chains of Ile158, Gln225, Tyr338, and
Tyr344. This environment stabilizes the protonated state of
Glu162 at the optimum pH of the reaction (pH 5.0), which
enables Glu162 to have a hydrogen bonding interaction with
the glycosidic oxygen of the scissile bond. It is the only acid
in the peptidoglycan-binding cleft of Slt35, and its position
coincides with the catalytic acid/base Glu478 of Slt70 after
superposition (9). Furthermore, a Glu162Gln mutation
yielded an inactive enzyme (9). From this, we conclude that
Glu162 is the catalytic acid/base in the reaction catalyzed
by Slt35.
During the cleavage reaction, a positively charged oxo-
carbonium ion-like intermediate is likely to occur. The
oxocarbonium ion should be shielded from the solvent to
allow attack by the -1 MurNAc O6 atom and to prevent a
hydrolysis reaction. For Slt70, it has been proposed that the
NH2+ moiety of the bulgecin hydroxyproline mimics the
oxocarbonium ion intermediate (26). If this is also true for
Slt35, the bulgecin NH2+ group should be shielded from the
solvent as well. Comparison of the binary and ternary Slt35-
bulgecin A complexes shows that the +1 GlcNAc O3 and
O4 atoms replace two water molecules that interact with the
-1 hydroxyproline NH2+ group of bulgecin (Figure 4B,C).
These water molecules could mimic the hydrolytic water
molecule attacking the oxocarbonium intermediate. Thus, a
prolonged presence of a GlcNAc residue in the +1 site could
prevent such a hydrolysis reaction.
The peptide bond between the hydroxyproline and taurine
parts of bulgecin A is supposed to mimic an N-acetyl group
that stabilizes the oxocarbonium ion intermediate (26). In
Slt70, the O and N atoms of this peptide bond are hydrogen
bonded to the Oç of Ser487 and the carboxylate group of
Glu583, respectively. In Slt35, Ser216 occupies a position
equivalent to Ser487 and forms a hydrogen bond to the
taurine peptide carbonyl oxygen atom. No residue has been
identified in Slt35 that can take over the role of Glu583 of
Slt70. Nevertheless, a superposition of the substrate com-
plexes of Slt35 and Slt70 shows that around the position of
the Glu583 carboxylate group in Slt70, five hydrogen bond
donors are present in Slt35: Nä2 of Asn339, N2 of Gln98,
NH of L-Ala in subsite -1, N10 of bulgecin A (which would
correspond to the N2 of a MurNAc residue), and the O6-
hydroxyl group of GlcNAc in subsite +1. Because a free
carboxylate group can accept four to five hydrogen bonds,
it is tempting to assume that these hydrogen bond donors
create a binding site for a free carboxylate group, which can
stabilize the reaction intermediate. Such a carboxylate group
could come from the peptidoglycan substrate itself, which
would explain why the peptide chains of peptidoglycan are
absolutely required for activity (16). One possibility would
be the free carboxylate group of the -1 D-Glu residue. This
group makes, however, a salt bridge to the side chain of
Arg187 and is therefore unlikely to supply the stabilizing
carboxylate group. However, the +2 D-Glu residue has a
free carboxylate group which can be modeled into the
carboxylate binding pocket (data not shown).
On the basis of our crystallographic studies and what is
known for Slt70 (26) and other polysaccharide-degrading
enzymes (30, 31), we propose the following reaction mech-
anism for Slt35 (Figure 6). In the first step, Slt35 binds the
nonreducing end of a peptidoglycan strand at subsites -2,
-1, +1, and +2 (see Table 2 for the Slt35 residues involved
in the binding of peptidoglycan). The terminal GlcNAc
residue is bound in subsite -2, because Slt35 acts as an exo-
muramidase, which starts at the nonreducing GlcNAc end
of a peptidoglycan strand and processively releases 1,6-
anhydromuropeptides (9, 16). Binding of peptidoglycan at
subsites -2 and -1 triggers small active site movements
(induced fit), which allow optimization of the binding
interactions. The N-acetyl group of the -1 MurNAc is
oriented and stabilized by Ser216. The free carboxylate of
the -2 D-Glu may interact with the N-acetyl group as well.
The MurNAc sugar ring is believed to be distorted from a
ground-state chair into the more reactive sofa conformation.
A distortion of the -1 sugar from the ground state to the
sofa form would optimize the overlap of the C1-O4 ó*
antibonding orbital and one of the lone pairs of the O5 atom
and thereby weaken the C1-O4 bond (32). The weakened
scissile bond can now easily be cleaved with concomitant
protonation of the glycosidic O4 oxygen by the protonated
O1 atom of Glu162. Cleavage of the glycosidic bond results
in the formation of a positively charged -1 MurNAc
oxocarbonium ion and a negatively charged Glu162. The
negative charge of the Glu162 carboxylate group may be
stabilized by three hydrogen bonds with the Tyr344 hydroxyl
group, the -1 MurNAc O6-hydroxyl group, and the +1
GlcNAc O4-hydroxyl group. The positively charged oxo-
carbonium ion is probably stabilized by the N-acetyl oxygen
of MurNAc, either by a charge-charge interaction or by a
covalent oxazolinium intermediate. This is similar to what
has been proposed for Slt70 (26) and chitin-degrading
enzymes (30, 33). The reaction intermediate in Slt35 is
shielded from the solvent by the N-acetyl group of the -1
MurNAc, the +1 GlcNAc, the +2 D-Glu, and Asn339, which
prevents a nucleophilic attack by a water molecule. To form
the 1,6-anhydro bond, the MurNAc residue needs to change
from a sofa into a boat conformation to bring the O6 atom
closer to the C1 atom for nucleophilic attack. Thereby, the
O2 atom of Glu162 could enhance the nucleophilicity of
the O6 atom by abstracting its proton. This would result in
the formation of a negatively charged O6 atom, which might
be stabilized by Asn339. In the Slt35-bulgecin A complexes,
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the Nä2 atom of Asn339 is found within hydrogen bonding
distance of the O9 atom of bulgecin A, which is in a position
similar to the -1 MurNAc O6 atom. It is therefore probable
that Asn339 facilitates the proton abstraction of the O6 atom
by Glu162. The subsequent attack by the O6 atom on the
positively charged C1 atom would yield the 1,6-anhydro
bond in the MurNAc residue. Finally, the 1,6-anhydro-
muropeptide is released, and the GlcNAc and MurNAc
residues in subsites +1 and +2 may move to subsites -2
and -1. The enzyme is now ready for a new catalytic cycle.
The study presented here shows that three residues in
subsite -1 of Slt35 may play an important role in the binding
and cleavage of peptidoglycan: Glu162, Ser216, and Asn339.
In E. coli Slt70, the equivalent residues are Glu478, Ser487,
and Asn553. These three residues are strictly conserved
among all known MltB/Slt35 and Slt70 lytic transgly-
cosylases, as shown by amino acid sequence analyses (9,
28). Site-directed mutagenesis studies have already shown
that mutation of the catalytic Glu into a Gln residue resulted
in inactive enzymes (7, 9). Mutation of the other two residues
could unambiguously demonstrate their importance in the
reaction mechanism of lytic transglycosylases.
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FIGURE 6: Proposed reaction mechanism of Slt35 (see the text for an explanation). The X indicates a carboxylate group of peptidoglycan.
Table 2: Residues in the Peptidoglycan-Binding Cleft of Slt35a
subsite -2 GlcNAc Arg188, Tyr191, Gly224, Gln225, Phe226, Met227, Ser230, Tyr259, Arg337, Tyr338, His340
subsite -1 MurNAc Met95, Gln98, Glu162, Arg188, Tyr191, Phe192, Ser216, Ala218, Ala220, Gln225, Met227, Tyr338, Asn339, Tyr344
L-Ala Gln98, Arg188
D-Glu Gln98, Ala99, Pro100, Arg187, Arg188, His340
subsite +1 GlcNAc Tyr117, Phe121, Val161, Glu162, Val168, Met169, Gln170, Ser216, Gln225, Asn339, Tyr344
subsite +2 MurNAc Lys120, Phe121, Gly160, Val161, Glu162, Thr163, Arg164, Val168
L-Ala Tyr117, Lys120, Phe121
D-Glu Tyr117, His343
a Residues of Slt35 within 4.5 Å of murodipeptides A and B, bulgecin A, and (GlcNAc)2. The underlined residues are or can be involved in the
hydrogen bonding with the peptidoglycan residues (within 3.5 Å) based on the three crystal structures.
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